<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02393651</url>
  </required_header>
  <id_info>
    <org_study_id>MEC-2014-503</org_study_id>
    <secondary_id>NL49887.078.14</secondary_id>
    <nct_id>NCT02393651</nct_id>
  </id_info>
  <brief_title>Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients</brief_title>
  <official_title>Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: About 80% of stroke patients suffer motor impairments, but current therapies have&#xD;
      limited effects on motor recovery. Therefore, investigating new potential therapeutic&#xD;
      approaches is crucial. Transcranial Direct Current Stimulation (tDCS) is a form of&#xD;
      non-invasive electrical stimulation where a weak current is applied through electrodes over&#xD;
      the scalp. This stimulation is known to (1) induce changes in neuronal excitability -which&#xD;
      can last up to one day with late LTP-like plasticity protocols in a polarity and&#xD;
      site-specific manner, and (2) facilitate motor learning and stroke recovery. So far, several&#xD;
      pilot studies have reported beneficial results from tDCS in both subacute and chronic stroke&#xD;
      patients, but it's still unclear how tDCS should be repeated over multiple days to optimally&#xD;
      enhance recovery and training effects. Using a late LTP-like plasticity protocol could&#xD;
      increase effectiveness of standard clinical care rehabilitation sessions and thus enhance the&#xD;
      effects of rehabilitation. Therefore, the investigators want to investigate how late LTP-like&#xD;
      plasticity tDCS affects rehabilitation in subacute stroke patients. The outcome of this study&#xD;
      can provide important guidelines on effective motor therapy during stroke rehabilitation.&#xD;
&#xD;
      Objective: Identify the effect of late LTP-like plasticity on motor rehabilitation during the&#xD;
      subacute phase after stroke.&#xD;
&#xD;
      Study design: Double-blinded, randomized between-subjects trials. Study population: Subacute&#xD;
      stroke patients. Main study parameters/endpoints: The primary outcome measure is the upper&#xD;
      limb motor function during the subacute phase after stroke.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Upper Extremity Fugl Meyer Assessment</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ARAT</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand grip strength</measure>
    <time_frame>Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10-meter walk test</measure>
    <time_frame>Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol-5D</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel Index</measure>
    <time_frame>Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HADS</measure>
    <time_frame>Baseline; 4 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MoCA</measure>
    <time_frame>Baseline; 4 weeks and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wong-Baker FACES Pain Rating Scale</measure>
    <time_frame>Every stimulation session</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Stroke</condition>
  <condition>Hemiparesis</condition>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Motor training of the affected upper extremity combined with sham tDCS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Motor training of the affected upper extremity combined with dual transcranial direct current stimulation (tDCS).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>Late LTP-like plasticity tDCS (2 times per week) for 4 weeks.</description>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_label>tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subacute stroke (within 1-4 weeks post stroke)&#xD;
&#xD;
          -  Acute hemiparesis (Fugl-Meyer Stage &lt; IV) with single thromboembolic non-hemorrhagic&#xD;
             infarction documented by a neurologist&#xD;
&#xD;
          -  Aged 18-79&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absence of voluntary movement (Fugl-Meyer Stage &lt; III)&#xD;
&#xD;
          -  Head injury or the presence of intracranial metal or intracranial lesions&#xD;
&#xD;
          -  History of cranial irradiation&#xD;
&#xD;
          -  History of epilepsy&#xD;
&#xD;
          -  Presence of a pacemaker&#xD;
&#xD;
          -  Taking anticonvulsant or neuroleptic medication&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Inability to understand instructions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rick van der Vliet, MSc</last_name>
    <phone>+31622857402</phone>
    <email>r.vandervliet@erasmusmc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rijndam</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <zip>3015LJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerard Ribbers, PhD MD</last_name>
      <phone>+31102412411</phone>
      <email>gribbers@rijndam.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>March 15, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <last_update_submitted>November 27, 2018</last_update_submitted>
  <last_update_submitted_qc>November 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Rick van der Vliet</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

